HomeCompareSAUHY vs JNJ

SAUHY vs JNJ: Dividend Comparison 2026

SAUHY yields 2.03% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SAUHY wins by $177.9K in total portfolio value
10 years
SAUHY
SAUHY
● Live price
2.03%
Share price
$10.32
Annual div
$0.21
5Y div CAGR
57.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$208.2K
Annual income
$102,257.93
Full SAUHY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SAUHY vs JNJ

📍 SAUHY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSAUHYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SAUHY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SAUHY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAUHY
Annual income on $10K today (after 15% tax)
$172.97/yr
After 10yr DRIP, annual income (after tax)
$86,919.24/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SAUHY beats the other by $82,933.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAUHY + JNJ for your $10,000?

SAUHY: 50%JNJ: 50%
100% JNJ50/50100% SAUHY
Portfolio after 10yr
$119.2K
Annual income
$53,473.66/yr
Blended yield
44.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SAUHY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
8.9
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAUHY buys
0
JNJ buys
0
No recent congressional trades found for SAUHY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSAUHYJNJ
Forward yield2.03%2.13%
Annual dividend / share$0.21$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR57.4%28%
Portfolio after 10y$208.2K$30.3K
Annual income after 10y$102,257.93$4,689.40
Total dividends collected$177.1K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: SAUHY vs JNJ ($10,000, DRIP)

YearSAUHY PortfolioSAUHY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,020$320.29$10,592$272.30+$428.00SAUHY
2$12,311$519.23$11,289$357.73+$1.0KSAUHY
3$14,026$853.25$12,123$472.89+$1.9KSAUHY
4$16,438$1,430.01$13,141$629.86+$3.3KSAUHY
5$20,054$2,465.31$14,408$846.81+$5.6KSAUHY
6$25,882$4,424.30$16,021$1,151.60+$9.9KSAUHY
7$36,093$8,399.71$18,122$1,588.22+$18.0KSAUHY
8$55,851$17,231.25$20,930$2,228.20+$34.9KSAUHY
9$98,984$39,223.20$24,792$3,191.91+$74.2KSAUHY
10$208,171$102,257.93$30,274$4,689.40+$177.9KSAUHY

SAUHY vs JNJ: Complete Analysis 2026

SAUHYStock

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Full SAUHY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SAUHY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAUHY vs SCHDSAUHY vs JEPISAUHY vs OSAUHY vs KOSAUHY vs MAINSAUHY vs ABBVSAUHY vs MRKSAUHY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.